John Overdeck’s Chemours CC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $28M | Buy |
1,362,389
+367,686
| +37% | +$8.42M | 0.02% | 846 |
|
|
2026
Q1 | $21.9M | Buy |
994,703
+251,190
| +34% | +$4.37M | 0.02% | 899 |
|
|
2025
Q4 | $8.77M | Sell |
743,513
-326,605
| -31% | -$4.19M | 0.01% | 1211 |
|
|
2025
Q3 | $17M | Sell |
1,070,118
-552,698
| -34% | -$8.02M | 0.03% | 699 |
|
|
2025
Q2 | $18.6M | Buy |
1,622,816
+80,375
| +5% | +$906K | 0.03% | 586 |
|
|
2025
Q1 | $20.9M | Buy |
1,542,441
+387,004
| +33% | +$6.43M | 0.04% | 473 |
|
|
2024
Q4 | $19.5M | Buy |
1,155,437
+211,641
| +22% | +$4.12M | 0.04% | 484 |
|
|
2024
Q3 | $19.2M | Sell |
943,796
-20,174
| -2% | -$412K | 0.04% | 499 |
|
|
2024
Q2 | $21.8M | Buy |
963,970
+695,965
| +260% | +$18.2M | 0.05% | 430 |
|
|
2024
Q1 | $7.04M | Sell |
268,005
-224,174
| -46% | -$6.39M | 0.02% | 793 |
|
|
2023
Q4 | $15.5M | Buy |
492,179
+254,951
| +107% | +$6.92M | 0.04% | 501 |
|
|
2023
Q3 | $6.65M | Buy |
+237,228
| New | +$8.15M | 0.02% | 772 |
|
|
2023
Q2 | – | Sell |
-21,200
| Closed | -$635K | – | 3035 |
|
|
2023
Q1 | $635K | Sell |
21,200
-3,000
| -12% | -$98.8K | ﹤0.01% | 2097 |
|
|
2022
Q4 | $741K | Sell |
24,200
-37,976
| -61% | -$1.14M | ﹤0.01% | 1851 |
|
|
2022
Q3 | $1.53M | Sell |
62,176
-49,824
| -44% | -$1.64M | 0.01% | 1272 |
|
|
2022
Q2 | $3.59M | Buy |
+112,000
| New | +$4.12M | 0.01% | 912 |
|
|
2022
Q1 | – | Sell |
-407,057
| Closed | -$13.7M | – | 2878 |
|
|
2021
Q4 | $13.7M | Buy |
407,057
+220,419
| +118% | +$6.87M | 0.03% | 638 |
|
|
2021
Q3 | $5.42M | Buy |
186,638
+147,238
| +374% | +$4.77M | 0.01% | 1173 |
|
|
2021
Q2 | $1.37M | Sell |
39,400
-31,073
| -44% | -$1.03M | ﹤0.01% | 2202 |
|
|
2021
Q1 | $1.97M | Sell |
70,473
-605,586
| -90% | -$16.1M | 0.01% | 1722 |
|
|
2020
Q4 | $16.8M | Buy |
676,059
+104,981
| +18% | +$2.5M | 0.05% | 424 |
|
|
2020
Q3 | $11.9M | Sell |
571,078
-441,424
| -44% | -$8.52M | 0.04% | 449 |
|
|
2020
Q2 | $15.5M | Buy |
1,012,502
+372,459
| +58% | +$4.71M | 0.08% | 272 |
|
|
2020
Q1 | $5.68M | Sell |
640,043
-631,998
| -50% | -$9.11M | 0.05% | 448 |
|
|
2019
Q4 | $23M | Buy |
1,272,041
+958,893
| +306% | +$15.9M | 0.07% | 330 |
|
|
2019
Q3 | $4.68M | Buy |
313,148
+216,150
| +223% | +$3.52M | 0.02% | 900 |
|
|
2019
Q2 | $2.33M | Buy |
+96,998
| New | +$2.86M | 0.01% | 1345 |
|
|
2018
Q3 | – | Sell |
-30,904
| Closed | -$1.37M | – | 3197 |
|
|
2018
Q2 | $1.37M | Sell |
30,904
-125,942
| -80% | -$6.27M | ﹤0.01% | 1900 |
|
|
2018
Q1 | $7.64M | Buy |
156,846
+122,781
| +360% | +$6.14M | 0.03% | 721 |
|
|
2017
Q4 | $1.71M | Sell |
34,065
-1,734,356
| -98% | -$90.8M | 0.01% | 1585 |
|
|
2017
Q3 | $89.5M | Buy |
1,768,421
+425,388
| +32% | +$20.1M | 0.32% | 71 |
|
|
2017
Q2 | $50.9M | Sell |
1,343,033
-891,656
| -40% | -$35.2M | 0.18% | 137 |
|
|
2017
Q1 | $86M | Buy |
2,234,689
+467,602
| +26% | +$14.1M | 0.29% | 64 |
|
|
2016
Q4 | $39M | Buy |
1,767,087
+802,556
| +83% | +$16.5M | 0.15% | 161 |
|
|
2016
Q3 | $15.4M | Buy |
964,531
+122,579
| +15% | +$1.4M | 0.06% | 394 |
|
|
2016
Q2 | $6.94M | Buy |
841,952
+434,581
| +107% | +$3.87M | 0.03% | 627 |
|
|
2016
Q1 | $2.85M | Sell |
407,371
-53,925
| -12% | -$271K | 0.01% | 970 |
|
|
2015
Q4 | $2.47M | Buy |
+461,296
| New | +$2.95M | 0.01% | 984 |
|
Other funds holding CC
CCPM
John Overdeck's CC Position: Q2 2026 in Review
John Overdeck increased its Chemours (CC) stake by 37% in Q2 2026, buying an estimated $8.42M and bringing the position to 1,362,389 shares worth $28M. The position accounts for 0.02% of the portfolio, ranked #846.
John Overdeck first reported a position in CC in Q4 2015 and has held it in 38 quarters since. The position peaked at $89.5M in Q3 2017. 469 funds tracked by Wall St. Rank hold CC as of Q2 2026.
- John Overdeck held 1,362,389 shares of Chemours worth $28M as of Q2 2026.
- John Overdeck bought 367,686 Chemours shares in Q2 2026, an estimated $8.42M.
- Chemours made up 0.02% of John Overdeck's portfolio in Q2 2026, its #846 holding.
- John Overdeck first reported a position in Chemours in Q4 2015 and has held it in 38 quarters since.
- John Overdeck's Chemours position peaked at $89.5M in Q3 2017.
- 469 funds tracked by Wall St. Rank held Chemours as of Q2 2026.
Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.